p53-MDM2-IN-3 (Compound 5s) is an orally active p53-MDM2 inhibitor with a Ki value of 0.25 μM. p53-MDM2-IN-3 exerts antitumor activity by inhibiting NF-κB pathway[1].

PA2G4 Human Pre-designed siRNA Set A contains three designed siRNAs for PA2G4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PABPC1 Human Pre-designed siRNA Set A contains three designed siRNAs for PABPC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PABPC3 Human Pre-designed siRNA Set A contains three designed siRNAs for PABPC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PABPC4 Human Pre-designed siRNA Set A contains three designed siRNAs for PABPC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PABPC4L Human Pre-designed siRNA Set A contains three designed siRNAs for PABPC4L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PABPN1 Human Pre-designed siRNA Set A contains three designed siRNAs for PABPN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PACC1 Human Pre-designed siRNA Set A contains three designed siRNAs for PACC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Paclitaxel octadecanedioate (compound PTX-FA18) is comprised of Paclitaxel (HY-B0015) conjugated to 1,18-octadecanedioic acid (HY-W005178). Paclitaxel octadecanedioate mixed with human serum albumin (HAS) is cytotoxic to HT-1080, PANC-1, HT-29 and Hela cells (IC50s = 12, 2.48, 8.62, and 64.42 nM, respectively)[1].

PACRG Human Pre-designed siRNA Set A contains three designed siRNAs for PACRG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PACS1 Human Pre-designed siRNA Set A contains three designed siRNAs for PACS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PACS2 Human Pre-designed siRNA Set A contains three designed siRNAs for PACS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PACSIN1 Human Pre-designed siRNA Set A contains three designed siRNAs for PACSIN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PACSIN2 Human Pre-designed siRNA Set A contains three designed siRNAs for PACSIN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PACSIN3 Human Pre-designed siRNA Set A contains three designed siRNAs for PACSIN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PADI1 Human Pre-designed siRNA Set A contains three designed siRNAs for PADI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PADI2 Human Pre-designed siRNA Set A contains three designed siRNAs for PADI2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PADI3 Human Pre-designed siRNA Set A contains three designed siRNAs for PADI3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PADI4 Human Pre-designed siRNA Set A contains three designed siRNAs for PADI4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PADI6 Human Pre-designed siRNA Set A contains three designed siRNAs for PADI6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Paenilagicin is a Gram-positive active antibiotic with a unique diphosphorylated prenyl binding mechanism that does not induce drug resistance. Paenilagicin exhibits a MIC value of 2 μg/mL against multidrug-resistant Gram-positive bacteria[1].

PAEP Human Pre-designed siRNA Set A contains three designed siRNAs for PAEP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAF1 Human Pre-designed siRNA Set A contains three designed siRNAs for PAF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAFAH1B1 Human Pre-designed siRNA Set A contains three designed siRNAs for PAFAH1B1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAFAH1B2 Human Pre-designed siRNA Set A contains three designed siRNAs for PAFAH1B2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAFAH1B3 Human Pre-designed siRNA Set A contains three designed siRNAs for PAFAH1B3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAFAH2 Human Pre-designed siRNA Set A contains three designed siRNAs for PAFAH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAG1 Human Pre-designed siRNA Set A contains three designed siRNAs for PAG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAGE1 Human Pre-designed siRNA Set A contains three designed siRNAs for PAGE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAGE2 Human Pre-designed siRNA Set A contains three designed siRNAs for PAGE2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAGE2B Human Pre-designed siRNA Set A contains three designed siRNAs for PAGE2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAGE3 Human Pre-designed siRNA Set A contains three designed siRNAs for PAGE3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAGE4 Human Pre-designed siRNA Set A contains three designed siRNAs for PAGE4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAGE5 Human Pre-designed siRNA Set A contains three designed siRNAs for PAGE5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAGR1 Human Pre-designed siRNA Set A contains three designed siRNAs for PAGR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAH Human Pre-designed siRNA Set A contains three designed siRNAs for PAH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.